INVESTORS
2020-08-17MMMM D, YYYY
IR call on the acquisition of Principia Biopharma Inc.
At a glance
R&D Days
July 30, 2020: Nirsevimab R&D investor event
June 23, 2020: Virtual R&D day event
June 11, 2020: Dupixent® R&D investor event
June 2, 2020: Oncology strategy and ASCO R&D investor event
April 23, 2020: BTKi ('168) R&D investor event
June 23, 2020: Virtual R&D day event
June 11, 2020: Dupixent® R&D investor event
June 2, 2020: Oncology strategy and ASCO R&D investor event
April 23, 2020: BTKi ('168) R&D investor event
Stock market
Half-Year Financial Report 2020
In-depth reading
2019 Integrated Report
Contact the Investor Relations team
54 rue La Boétie
75008 Paris FRANCE
France +33 (0)1 53 77 45 45 • ir@sanofi.com
United States +1 908 981 5560
For all general requests, please contact the Global Headquarters in France : +33 (0)1 53 77 40 00
Quick links
Individual shareholders
Access your dedicated section
Letter to shareholders August 2020
